Smith Shellnut Wilson
ASTH icon

Smith Shellnut Wilson’s Astrana Health ASTH Stock Holding History

Smith Shellnut Wilson’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-4,616
Closed -$214K – 167
2026
Q2 		$214K Buy
+4,616
New +$166K 0.08% 157
2024
Q4 		– Sell
-4,616
Closed -$267K – 154
2024
Q3 		$267K Buy
+4,616
New +$227K 0.12% 121

Other funds holding ASTH

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
SteelPeak Wealth
SteelPeak Wealth Woodland Hills, California $4.07B AUM 38.25% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
NorthCrest Asset Manangement
NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return
Insight Wealth Strategies
Insight Wealth Strategies San Ramon, California $1.01B AUM 28.81% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Hussman Strategic Advisors
Hussman Strategic Advisors Ellicott City, Maryland $469M AUM 10.16% 1-Year Est. Return
Linden Thomas Advisory Services
Linden Thomas Advisory Services Charlotte, North Carolina $1.26B AUM 37.95% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Smith Shellnut Wilson's ASTH Position: Q3 2026 in Review

Smith Shellnut Wilson sold out of Astrana Health (ASTH) in Q3 2026, closing a stake of 4,616 shares — an estimated $214K sold.

Smith Shellnut Wilson first reported a position in ASTH in Q3 2024 and held it in 2 quarters. The position peaked at $267K in Q3 2024. 77 funds tracked by Wall St. Rank hold ASTH as of Q3 2026.

  • Smith Shellnut Wilson reported no remaining Astrana Health position as of Q3 2026 after selling out during the quarter.
  • Smith Shellnut Wilson sold 4,616 Astrana Health shares in Q3 2026, an estimated $214K.
  • Smith Shellnut Wilson first reported a position in Astrana Health in Q3 2024 and held it in 2 quarters.
  • Smith Shellnut Wilson's Astrana Health position peaked at $267K in Q3 2024.
  • 77 funds tracked by Wall St. Rank held Astrana Health as of Q3 2026.

Based on Smith Shellnut Wilson's 13F filing for Q3 2026, filed 21 Oct 2026.